Fundraising Fox
IpiNovyx Bio
West Nyack, US · Founded 2021 · Delaware corporation · 4 employees on LinkedIn · 2 known investors
Find your way into IpiNovyx Bio
Sign up to see every warm intro you have to IpiNovyx Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the IpiNovyx Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Its technology originated from research at Weill Cornell Medicine and the Hospital for Special Surgery, and it is advancing these preclinical programs toward clinical applications.
Founders & leadership
IpiNovyx Bio was founded in 2021 by Gang Lin, Carl Nathan, and Franck Barrat.
Investors · 2
How we know: Pathway Bioventures's portfolio page · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2021
▶$7MraisedOct 2021 · 12 investors · Other Health CareRule 506(b)
- Marc AppelExecutive Officer, Director
- Lutz GiebelDirector
- James GrahamDirector
- Offering amount
- $10M
- Amount sold
- $7M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does IpiNovyx Bio do?
- IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Its technology originated from research at Weill Cornell Medicine and the Hospital for Special Surgery, and it is advancing these preclinical programs toward clinical applications.
- Who founded IpiNovyx Bio?
- IpiNovyx Bio was founded by Gang Lin, Carl Nathan, Franck Barrat in 2021.
- Who are IpiNovyx Bio's investors?
- IpiNovyx Bio's investors include Pathway Bioventures, Alexandria.
- How much funding has IpiNovyx Bio raised?
- IpiNovyx Bio has disclosed $7M raised across 1 round.
- Where is IpiNovyx Bio headquartered?
- IpiNovyx Bio is headquartered in West Nyack, US.